Article Text
Statistics from Altmetric.com
Context
Hepatitis B (HBV) remains a global health concern with 350 million people chronically infected, and transmission still occurs despite the widely available and efficacious vaccine. Mother-to-child transmission (MTCT) is an ongoing problem in many countries, and in countries with high prevalence of HBV (>8%), only 44% have birth dose vaccine implemented into the infant vaccine schedule.1 Currently, the Centers for Disease Control and Prevention recommends the use of hepatitis B immune globulin (HBIG) and HBV vaccine given at the time of birth with two additional doses of the vaccine in the first 6 months of life to …
Footnotes
-
Competing interests None.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.